English | Español
Patient Daily | Feb 4, 2026

AstraZeneca signs $1.2B obesity drug deal with CSPC Pharmaceutical
Patient Daily | Feb 4, 2026

Baylor psychiatrist highlights risks associated with rising sports gambling trends
Patient Daily | Feb 4, 2026

Wastewater monitoring uncovers hidden COVID-19 spread as clinical testing declines
Patient Daily | Feb 4, 2026

New framework aims to improve detection of rapidly mutating RNA viruses
Patient Daily | Feb 4, 2026

New platform integrates digital microfluidics with 3d printing for improved cell culture
Patient Daily | Feb 4, 2026

Microneedle patch enables dual drug delivery for improved acne therapy
Patient Daily | Feb 4, 2026

Dynamic viral markers help predict response to hepatitis B treatment
Patient Daily | Feb 4, 2026

Metacognitive therapy may reduce mental health-related sick leave costs in Norway

Trending
+ Pharmaceuticals
Patient Daily | Apr 5, 2026

Amplifon announces $2 billion acquisition of GN Hearing in strategic shift
Patient Daily | Apr 7, 2026

ProPublica examines impact of RFK Jr.'s vaccine policies on childhood disease risks
+ Pharmaceuticals
Patient Daily | Apr 1, 2026

Biopharma mergers and acquisitions reach $46.8 billion in first quarter of 2026
+ Regulatory
Patient Daily | Apr 8, 2026

Columbia University Professor Masia on 340B: '340B has become a drug mark-up program. Hospitals buy drugs at low cost and sell them high'